This mini review emphasizes the fact that tobacco smoking causes small but real biologic brain changes that need to be studied in depth. A crucial question is whether these anatomical/chemical changes reverse toward normal when smokers quit. This review is presented to stimulate further research to answer this question.
Tobacco smoking/nicotine
Basic science studies indicate that fetal and adolescent rats given chronic nicotine show persistent neurochemical and pathological brain changes (Trauth et al., 1999 (Trauth et al., , 2000 Xu et al., 2001; Chen et al., 2003) . Furthermore, it is well known that tobacco smoking during pregnancy increases spontaneous miscarriages, retards fetal growth, induces premature birth, and increases the risk of sudden infant deaths. The recent review by Shea and Steiner (2008) stresses the pathophysiological mechanisms by which nicotine, as one of the major substances in tobacco smoke, is involved. Less appreciated is the fact that chronic tobacco smoking induces subtle anatomical and chemical brain changes in normal adults. In view of the chronic cardiovascular effects of nicotine/tobacco smoking, it is no surprise that both silent and symptomatic strokes are more prevalent in smokers than nonsmokers (Howard et al., 1998; Longstreth et al., 1998) . In addition, there have been greater periventricular white matter hyperintensities in tobacco smokers reported in some studies (Fukuda and Kitani 1996; Kobayashi et al., 1997; Liao et al., 1997; Jeerakathil et al., 2004; Longstreth et al., 2000; Tsushima et al., 2002) , but not in all (Yetkin et al., 1993; Yamashita et al., 1996) . The greater the pack-year smoking history, the greater sulcal and ventricular size and brain atrophy in elderly smokers (Longstreth et al., 2000 (Longstreth et al., , 2001 . Vermeer et al. (2003) reported on the incidence and the risk factors associated with silent brain infarcts. Tobacco smoking, with its associated vascular complications, is certainly an important factor to consider. The silent infarcts would not be expected to be reversible upon quitting smoking.
The availability of magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) has stimulated further brain anatomical and chemical studies in younger tobacco smokers to detect subtle brain differences of possible pathological significance. Brody et al. (2004) , using MRI, found that tobacco smokers compared to nonsmokers had smaller brain gray matter volumes and/or densities in bilateral prefrontal cortex, left dorsal anterior cingulate cortex, and right cerebellum. Greater pack-year smoking histories were found to be related to reduced prefrontal gray matter densities. Brody et al. (2004) commented that it was unknown whether predisposing factors that lead to smoking, the effects of chronic smoking, or a combination of factors were involved. Gallinat et al. (2006) also used MRI in a similar smoker/nonsmoker study. Smokers compared to nonsmokers had decreased anterior cingulate prefrontal and orbital frontal cortex gray matter volume and less gray matter density. Either gray matter volume or density was also decreased in the thalamus, cerebellum, and substantia nigra. Lifetime exposure to tobacco smoke correlated with decreased frontal, temporal, and cerebellar volumes. Recently, Paul et al. (2008) used diffusion tensor imaging (DTI) to study the microstructural integrity of white matter in a small group of healthy adult smokers and nonsmokers. Fractional anisotropy (FA) was used to measure directional water diffusion and "trace" as a measure of non-directional water diffusion. Higher FA and lower "trace" values indicate greater axonal integrity. The Fagerström test for nicotine dependence was used to assess the level of nicotine dependence. Higher scores represent a greater degree of dependence. Smokers with a high Fagerström dependence score had significantly lower FA in the body of the corpus callosum compared to smokers with a low Fagerström dependence score, and nonsmokers. It appears 
